Cutaneous T Cell Lymphomas News and Research

RSS
Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

PD1 gene deletions associated with worse prognoses of cutaneous T-cell lymphomas

PD1 gene deletions associated with worse prognoses of cutaneous T-cell lymphomas

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Research project to identify mechanisms underlying effects of cancer drug interferon-α

Research project to identify mechanisms underlying effects of cancer drug interferon-α

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010

Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010

Dendritic cells tricked into action against cancer

Dendritic cells tricked into action against cancer

Genmab's HuMax-CD4 receives U.S. orphan drug designation

Genmab's HuMax-CD4 receives U.S. orphan drug designation